Search

Search Results
Results 12131 - 12140 of 17261 for Active treatment
  • Trifeme
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Trifeme intended for persons living in Australia.
  • Minulet
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Minulet intended for persons living in Australia.
  • Exelon
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Exelon intended for persons living in Australia.
  • Thyrox
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Thyrox intended for persons living in Australia.
  • Minirin Tablets
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Minirin Tablets intended for persons living in Australia.
  • D-Penamine
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about D-Penamine intended for persons living in Australia.
  • Huntsman Cancer Institute expands reach to serve more patients in Utah with $20 million land donation
    News - 27 Jan 2024
    Huntsman Cancer Institute at the University of Utah (the U) has received a $20 million land donation from the developers of Utah City, a new walkable mixed-use city center.
  • 3D-printed liver model paves way for new MASH treatments
    News - 23 Jan 2024
    Metabolic dysfunction- associated steatohepatitis, or MASH, is an inflammatory, liver-scarring disease that has reached epidemic proportions, with an estimated 1.5% to 6.5% of U.S. adults afflicted by...
  • New biomarkers could help detect lupus nephritis earlier
    News - 22 Jan 2024
    New biomarkers with improved diagnostic performance for early detection of lupus nephritis have been discovered in the University of Houston lab of Chandra Mohan, a pioneer in lupus research.
  • How smart nanofiber meshes can be used as a local drug delivery platform
    White Paper - 22 Jan 2024
    This article from Merck outlines how nanofiber meshes are used as local drug delivery platforms.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback